Helena Linardou
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Cancer Research top 2%
- Surgery top 10%
- Co-authors
- Samuel MurrayDimitrios BafaloukosIssa J DahabrehP. KosmidisFotios SiannisChristos PapadimitriouGeorge FountzilasD. Kanaloupiti
- Topics
- Lung Cancer Treatments and Mutations (29 papers)HER2/EGFR in Cancer Research (16 papers)Cancer Genomics and Diagnostics (12 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Helena Linardou
82 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 899
- Cancer Research 653
- Surgery 293
Countries citing papers authored by Helena Linardou
This map shows the geographic impact of Helena Linardou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Linardou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Linardou more than expected).
Fields of papers citing papers by Helena Linardou
This network shows the impact of papers produced by Helena Linardou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Linardou. The network helps show where Helena Linardou may publish in the future.
Co-authorship network of co-authors of Helena Linardou
This figure shows the co-authorship network connecting the top 25 collaborators of Helena Linardou. A scholar is included among the top collaborators of Helena Linardou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Linardou. Helena Linardou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 5 | |
| 7 | 15 | |
| 8 | 3 | |
| 9 | 11 | |
| 10 | 19 | |
| 11 | Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. | 6 |
| 12 | 10 | |
| 13 | 23 | |
| 14 | Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel. | 12 |
| 15 | 61 | |
| 16 | 39 | |
| 17 | 53 | |
| 18 | 116 | |
| 19 | 94 | |
| 20 | 9 |
About Helena Linardou
Helena Linardou is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 87 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), HER2/EGFR in Cancer Research (16 papers) and Cancer Genomics and Diagnostics (12 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (653 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Helena Linardou has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Samuel Murray, Dimitrios Bafaloukos, Issa J Dahabreh, P. Kosmidis, Fotios Siannis, Christos Papadimitriou, George Fountzilas, D. Kanaloupiti, Helen Gogas and Evangelos Briasoulis. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.